WHO agrees on Italian resolution on transparency in drug costs

On May 28th, 2019, World Health Organization (WHO) members agreed by consensus to adopt the draft of a  resolution on improving the transparency of markets for drugs, vaccines and other health-related technologies. This resolution had been originally proposed by Italy in February 2019, an Italian representatives worked to build support among WHO member states. This effort was conducted jointly by the Minister of Health, the Italian Medicines Agency (AIFA), the Minister of Foreign Affairs and International Cooperation, and civil society. The agreed upon text of the resolution “urges member states in accordance with their national and regional legal frameworks and contexts” to make  information on net prices public, and to support dissemination, availability and overall transparency of procurement price data. The final resolution stopped short, though, of empowering WHO to collect and analyze concrete data on drug manufacturer's production costs, which had been the central aim of earlier drafts of the resolution.

News article - Reuters

Italy Global health R&D